Dermatophytosis Treatment Market Trends, Size, Growth, Share, Segments 2024-2033

The new report published by The Business Research Company, titled ""Dermatophytosis Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the dermatophytosis treatment market size has grown strongly in recent years. It will grow from $9.76 billion in 2023 to $10.38 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The dermatophytosis treatment market size is expected to see strong growth in the next few years. It will grow to $13.36 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15787&type=smp

Fungal Infections Fuel Dermatophytosis Market Growth
The increasing number of fungal infections among people globally is expected to propel the growth of the dermatophythosis treatment market going forward. A fungal infection is a health condition caused by the overgrowth of fungi on or inside the body, resulting in symptoms such as itching, redness, and discomfort. Fungal infections are increasing due to a combination of factors, including climate change, globalization, urbanization, and the growing population of immunocompromised individuals. Dermatophytosis treatment is used to treat fungal infections on the skin, hair, and nails caused by certain types of fungi, helping to relieve symptoms and stop the infection from spreading. For instance, in July 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, fungal infection-related hospitalizations reached a total of 59,212 till 2021, with the rate of these hospitalizations increasing from 25.0 in 2020 to 26.8 in 2021 per 10,000 hospitalizations, with an average annual increase of 8.5%. The rising burden of fungal infections among people globally is expected to propel the growth of the dermatophythosis treatment market.

Focus On Advanced Topical Treatments To Enhance Efficacy And Patient Satisfaction
Major companies operating in the dermatophythosis treatment market are focusing on developing topical treatments, such as powder and cream, to improve treatment efficacy and enhance patient satisfaction, aiming to address the evolving needs of the market. The powder and cream for dermatophytosis are used to reduce itching, absorb moisture, inhibit fungal growth, heal, and prevent further spread of the infection. For instance, in May 2022, Bayer, a Germany-based life science, healthcare, and nutrition company, launched canesten powder and cream. This product provides relief from a range of fungal skin infections, including ringworm, jock itch, skin candidiasis, athlete's foot, erythrasma, and fungal nail infections. The product provides 5X as much relief as ordinary talcum powder from prickly heat, redness, skin irritation, itching, and fungal infection.

The dermatophytosis treatment market covered in this report is segmented -

1) By Type: Prescribed, Over The Counter
2) By Product Type: Anti-infective, Antifungal, Steroids, Other Product Types
3) By Route Of Administration: Oral, Topical
4) By End User: Hospital, Clinic, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15787&type=discount

Major companies operating in the dermatophytosis treatment market are Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Astellas Pharma Inc., Valeant Pharmaceuticals International Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Fougera Pharmaceuticals Inc., Galderma S.A., Dr. Reddy's Laboratories Ltd., AmDerma Pharmaceuticals LLC, LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Quinnova Pharmaceuticals Inc., Enzon Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Dermatophytosis Treatment Market Report Structure
3. Dermatophytosis Treatment Market Trends And Strategies
4. Dermatophytosis Treatment Market - Macro Economic Scenario
5. Dermatophytosis Treatment Market Size And Growth
…..
27. Dermatophytosis Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/dermatophytosis-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.